Filter
8
Text search:
B.
C.
Zanoni
Featured
Language
Document type
No document type
5
Guidelines
3
Countries / Regions
Saudi Arabia
1
Zimbabwe
1
Syria
1
Chad
1
South Africa
1
Yemen
1
Middle East and North Africa
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
2
Clinical Guidelines
2
Women & Child Health
2
Toolboxes
HIV
4
COVID-19
3
TB
1
Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Центр лечения тяжелых острых респираторных инфекцийПрактическое руководство по организации центра лечения ТОРИ ицентра проведения скрининга на ТОРИ на базе мед
...
آذار / مارس 2020مركز معالجة حالات العدوى التنفسیة الحادة الوخیمةدلیل عملي لإنشاء وإدارة مركز لمعالجة حالات العدوى التنفسیة الحادة الوخیمة وقسم لتحري المصابین بھذه ا
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.